// App-Quantinova.ai

BSH2020‐PO‐046 : Transition to generic imatinib: a single‐centre experience of patient and financial outcomes

Researchers

Presenter

  • G. Hess

Principal Investigators

  • N. Kaciubskyj

  • A. Collins

Medical Centers

  • Norfolk & Norwich UniversityHospitals, Norfolk, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

Biomarkers

  • Abelson murine leukemia viral oncogene homolog

  • Breakpoint Cluster Region

  • Cluster of Differentiation 206

Drug/Treatment

  • Imatinib

  • IkT001

  • L-Tyrosine

  • Gleevec

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved